Search research articles
Contact Us
Filters
Showing results (121-130 of 225) with videos related to
Page
of 23
Sort By:
Blood Neoplasia
|
August 14, 2025
The oral CDK9 inhibitor voruciclib combined with venetoclax for patients with relapsed/refractory acute myeloid leukemia
Yesid Alvarado-Valero, Rachel J Cook, Shira N Dinner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2018
Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Matthew S Davids, Michael Hallek, William Wierda, et al.
Leukemia & Lymphoma
|
October 17, 2018
Ofatumumab plus high dose methylprednisolone followed by ofatumumab plus alemtuzumab to achieve maximal cytoreduction prior to allogeneic transplantation for 17p deleted or TP53 mutated chronic lymphocytic leukemia<sup>.</sup>
Matthew S Davids, Haesook T Kim, Lijian Yu, et al.
Blood
|
October 5, 2016
Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103
Chaitra S Ujjani, Sin-Ho Jung, Brandelyn Pitcher, et al.
Blood
|
September 30, 2025
Mechanisms of immune escape and extramedullary tropism in leukemia cutis
Livius Penter, Katie Maurer, Nicoletta Cieri, et al.
American Journal of Hematology
|
April 8, 2026
Recurrent Genomic Alterations in BCRi-Experienced CLL Patients Treated With Venetoclax: Extended Phase 2 Follow-Up
Jennifer A Woyach, Relja Popovic, Emily L Rossi, et al.
Blood
|
November 17, 2021
Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome
Matthew S Davids, Kerry A Rogers, Svitlana Tyekucheva, et al.
Blood Advances
|
April 10, 2020
The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites
Anthony Mato, Chadi Nabhan, Nicole Lamanna, et al.
Haematologica
|
March 30, 2019
Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy
Anthony R Mato, William G Wierda, Matthew S Davids, et al.
Cancer Discovery
|
December 18, 2016
Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax
Joan Montero, Jason Stephansky, Tianyu Cai, et al.
Page
of 23
Search research articles
Search
Showing results (121-130 of 225) with videos related to
Sort By:
Page
of 23
Blood Neoplasia
|
August 14, 2025
The oral CDK9 inhibitor voruciclib combined with venetoclax for patients with relapsed/refractory acute myeloid leukemia
Yesid Alvarado-Valero, Rachel J Cook, Shira N Dinner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2018
Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Matthew S Davids, Michael Hallek, William Wierda, et al.
Leukemia & Lymphoma
|
October 17, 2018
Ofatumumab plus high dose methylprednisolone followed by ofatumumab plus alemtuzumab to achieve maximal cytoreduction prior to allogeneic transplantation for 17p deleted or TP53 mutated chronic lymphocytic leukemia<sup>.</sup>
Matthew S Davids, Haesook T Kim, Lijian Yu, et al.
Blood
|
October 5, 2016
Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103
Chaitra S Ujjani, Sin-Ho Jung, Brandelyn Pitcher, et al.
Blood
|
September 30, 2025
Mechanisms of immune escape and extramedullary tropism in leukemia cutis
Livius Penter, Katie Maurer, Nicoletta Cieri, et al.
American Journal of Hematology
|
April 8, 2026
Recurrent Genomic Alterations in BCRi-Experienced CLL Patients Treated With Venetoclax: Extended Phase 2 Follow-Up
Jennifer A Woyach, Relja Popovic, Emily L Rossi, et al.
Blood
|
November 17, 2021
Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome
Matthew S Davids, Kerry A Rogers, Svitlana Tyekucheva, et al.
Blood Advances
|
April 10, 2020
The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites
Anthony Mato, Chadi Nabhan, Nicole Lamanna, et al.
Haematologica
|
March 30, 2019
Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy
Anthony R Mato, William G Wierda, Matthew S Davids, et al.
Cancer Discovery
|
December 18, 2016
Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax
Joan Montero, Jason Stephansky, Tianyu Cai, et al.
Page
of 23